Project description:SChLAP1 is a novel long non-coding RNA expressed in prostate cancer. Here we performed transcriptional profiling of the prostate cancer cell lines LNCaP and 22Rv1 comparing non-targeting siRNA treatment versus SChLAP1-siRNA treatment. Goal was to determine the effect of SChLAP1 knockdown on gene expression in prostate cancer. Two-condition experiment: non-targeting siRNA versus SChLAP1 siRNA treated cells. Biological replicates: 1 control replicate, 2 treatment replicates. Technical replicates: 3 replicates per SChLAP1 siRNA. Cell lines: 22Rv1 and LNCaP.

2013-07-20 | E-GEOD-40383 | biostudies-arrayexpress

Targeting GATA2 in prostate cancer with K11706 (1)

Project description:Targeting GATA2 in prostate cancer with K11706 (1)

| PRJNA613260 | ENA

Targeting GATA2 in prostate cancer with dilazep (1)

Project description:Targeting GATA2 in prostate cancer with dilazep (1)

| PRJNA613263 | ENA

Therapeutic targeting of splicing in aggressive prostate cancer

Project description:Therapeutic targeting of splicing in aggressive prostate cancer

| PRJNA527978 | ENA

Targeting p300/CBP axis in lethal prostate cancer

Project description:Targeting p300/CBP axis in lethal prostate cancer